RadMD

The Imaging Experts. Imaging Solutions for Clinical Trials. Stop here. Take a Breath. Challenges Welcome.

[RadMD @radmdllc]

We are introducing two new modules on our training platform BRITI called RECIST 1.1 & CRA Immuno-Oncology Response Criteria. By using these modules you can improve the way you monitor your clinical trials and receive continuing education credit. 👉 https://t.co/LzHXQsnNBa

[World Health Organization (WHO) @WHO]

👏👏👏👏👏👏👏👏👏👏👏
👏👏👏👏👏👏👏👏👏👏👏
👏👏👏👏👏👏👏👏👏👏👏
👏#ThanksHealthHeroes👏
👏👏👏👏👏👏👏👏👏👏👏
👏👏👏👏👏👏👏👏👏👏👏
👏👏👏👏👏👏👏👏👏👏👏
👏👏👏👏👏👏👏👏👏👏👏
#WorldHealthDay

[RadMD @radmdllc]

They don’t call us the #ImagingExperts for nothing! Doesn’t your trial deserve the best readers? Check our our website: https://t.co/uySM3HDzZ8 for more information! 🧬🦠🔬

[Andy Biotech @AndyBiotech]

The vascular side of #Alzheimer's disease
https://t.co/M4x9Rt3Cb8

Very interesting new paper on whether vascular dysfunction might be an intermediate pathophysiological process between Aβ accumulation and neurodegeneration in AD.
https://t.co/wciUneHXxe
#AAIC19

[Boehringer Ingelheim @Boehringer]

How do we approach #digitaltransformation in #healthcare? Our CFO Michael Schmelmer explains how #speechrecognition could help detect the risk of developing #Schizophrenia at an early stage. #digitalbenefits

[RadMD @radmdllc]

We are proud to have been a table host sponsor for the @ACSCAN Action Breakfast. ACS Cancer is advocating for a 2.5 billion dollar increase in NIH funding, which will help cancer patients all across America! Find out how you can help below. 👇
https://t.co/ESzvS7QLju

[RadMD @radmdllc]

Welcome to the #RadMD’s official Twitter page. We are so excited to
be sharing special announcements, industry news, and more! Check out our website for more information. https://t.co/vSZz3wadN5 🧬